62.15
-1.02(-1.61%)
Currency In USD
| Previous Close | 63.17 |
| Open | 63.98 |
| Day High | 64.39 |
| Day Low | 61.1 |
| 52-Week High | 69.36 |
| 52-Week Low | 10.14 |
| Volume | 542,363 |
| Average Volume | 789,909 |
| Market Cap | 1.58B |
| PE | -8.15 |
| EPS | -7.63 |
| Moving Average 50 Days | 59.7 |
| Moving Average 200 Days | 31.71 |
| Change | -1.02 |
If you invested $1000 in Cidara Therapeutics, Inc. (CDTX) 10 years ago, it would be worth $207.72 as of September 09, 2025 at a share price of $62.15. Whereas If you bought $1000 worth of Cidara Therapeutics, Inc. (CDTX) shares 5 years ago, it would be worth $1,067.87 as of September 09, 2025 at a share price of $62.15.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cidara Therapeutics to Participate in September Investor Conferences
GlobeNewswire Inc.
Sep 04, 2025 12:00 PM GMT
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced that company management will
Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting
GlobeNewswire Inc.
Sep 03, 2025 12:00 PM GMT
SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced it will have two oral presen
Cidara Therapeutics to Report Second Quarter 2025 Financial Results and Host Quarterly Conference Call on August 7, 2025
GlobeNewswire Inc.
Jul 24, 2025 12:00 PM GMT
SAN DIEGO, July 24, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that it will report its se